Product
Trelegy
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
The Efficacy of Fluticasone Furoate/Vilanterol/Umeclidinium Compared With Vilanterol/Umeclidinium in Reducing Air Trapping and Airway and Blood Cytokine Levels in COPDStatus: Not yet recruiting, Estimated PCD: 2026-06-01